• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

National Access Cannabis Signs Deal with The Hydroponics Company

December 6, 2017


THC to license NAC's successful medical clinic model for replication in the Australian and New Zealand markets


OTTAWA, Dec. 6, 2017 /CNW/ - National Access Cannabis Corp. ("NAC" or the "Company") (TSX VENTURE: NAC), Canada's best practices leader in delivering secure, safe, and responsible access to legal medical cannabis, today announced that it has signed a binding license agreement ("the agreement") with The Hydroponics Company Limited. ("THC") (ASX: THC), whereby THC will license NAC's medical clinic operation model for an initial period of 10 years in Australia and New Zealand. The agreement also permits THC to extend the licensing agreement for an additional period of 10 years, with first right of refusal for potential development elsewhere in Asia.


Under the agreement, NAC has agreed to provide to THC exclusive access to certain intellectual property and marketing expertise of NAC in connection with the development of a professional cannabis clinic model in Australia and New Zealand. NAC will also provide THC with access to NAC's extensive relationships with Canadian Licenced Producers and new medicinal products. In consideration, THC has agreed to pay NAC a licensing fee of $500,000 Australian dollars upon or before the second anniversary of the agreement or upon successfully achieving an initial gross revenue milestone of $1,000,000 Australian dollars whichever occurs first. Thereafter, THC will pay NAC ongoing quarterly royalties equivalent to 7.5% of its gross revenue until such time as the licensing agreement expires.


"This agreement is an important first step in NAC's international expansion and the Australian medicinal cannabis market represents a prime region for development," said Mark Goliger, CEO of National Access Cannabis. "We look forward to sharing NAC's extensive experience and knowledge in successfully operating in Canada's growing cannabis market and leverage our clinical model to provide safe and secure access to medicinal cannabis products for patients in Australia and New Zealand, and to further developing the partnership between our two innovative and creative companies."


"We are delighted to partner with such a professional company as NAC," said David Radford, CEO of The Hydroponics Company. "Having visited their medical clinic in Ottawa, I believe that the quality processes and care that they have developed for their patients has a real and exciting place in the Australian marketplace."


About National Access Cannabis


National Access Cannabis is Canada's best practices leader in delivering secure, safe, and responsible access to legal medical cannabis. NAC enables patients to gain knowledge and the legal medical documentation required to navigate Canada's disparate network of authorized Licensed Producers of Cannabis. Through its Canada-wide network of care centres, NAC has partnered with health professionals to improve the quality of life of its local members and provide services designed to inform, educate and supply expert advice.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Reader Advisories


This press release contains forward-looking statements. More particularly, this press release contains forward-looking statements concerning the NAC's international expansion plans, the sharing of experience and knowledge with international partners, and the future relationships between the parties. The forward-looking statements contained in this document are based on certain key expectations and assumptions made by NAC. Although NAC believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because NAC cannot give any assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks associated with the medical and potential marijuana industry in general.

Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.